Interestingly, combining anti-PD-1 with SGT-53 was very effective in inhibiting GB growth, inducing tumor cell apoptosis and increasing intratumoral T cell infiltration, resulting in a significant survival benefit in mice bearing intracranial GB [989]. Here, PDCD1 is linked to neoplasm.